Studies indicate that the inhibition of TOPK could be a strategy for cancer chemoprevention and treatment [16], and examine the function of TOPK inhibitors, such as OTS964, which could inhibit glioma stem cell survival, but the surviving glioma stem cells eventually start to regrow [17]. This evidence concerns the gene PBK and central nervous system cancer.